Filing Details
- Accession Number:
- 0001225208-17-009195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-04 19:59:56
- Reporting Period:
- 2017-05-02
- Filing Date:
- 2017-05-04
- Accepted Time:
- 2017-05-04 19:59:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196661 | Jr E Donald Bobo | One Edwards Way Irvine CA 92614 | Cvp, Heart Valve Therapy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-02 | 10,000 | $44.62 | 82,095 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-02 | 10,000 | $110.05 | 72,095 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 18,720 | $25.48 | 90,815 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 400 | $44.62 | 91,215 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-03 | 400 | $110.10 | 90,815 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-03 | 13,720 | $109.72 | 77,095 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 10,000 | $44.62 | 87,095 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-04 | 10,000 | $110.27 | 77,095 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2017-05-02 | 10,000 | $0.00 | 10,000 | $44.62 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2017-05-03 | 400 | $0.00 | 400 | $44.62 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2017-05-03 | 18,720 | $0.00 | 18,720 | $25.48 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2017-05-04 | 10,000 | $0.00 | 10,000 | $44.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 82,800 | 2012-05-12 | 2018-05-11 | No | 4 | M | Direct |
| 82,400 | 2012-05-12 | 2018-05-11 | No | 4 | M | Direct |
| 0 | 2011-05-13 | 2017-05-12 | No | 4 | M | Direct |
| 72,400 | 2012-05-12 | 2018-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,431 | Indirect | 401(k) |
| Common Stock | 9,604 | Indirect | By Trust |
Footnotes
- This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $110.00 to $110.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.
- This transaction was executed in multiple trades at prices ranging from $110.03 to $110.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $109.28 to $110.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $110.60 to $110.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.
Billionaire Hedge Funds
